ExaVeyra SciencesExaVeyra Sciences

FDA, compounding and supply chain updates for your practice

Get the free Supplier Vetting Checklist when you subscribe

One email every Monday. Unsubscribe anytime. We never sell your email.

Authored by an organic chemist and built on the published work of dermatologists, clinical researchers and laboratory scientists. Each Monday it gathers the week's research reviews, regulatory updates and sourcing guides, with every claim cited.

  • Free, one email every Monday
  • Every claim cited to its source
  • Making complex science more accessible
The United States Capitol building in Washington, DC, under a clear sky

ExaBlog Weekly

By Benn Veyra, M.Sc., organic chemist

Monday

Supply chainSample issue

A Practice That Administers Prescription Drugs Is a Dispenser. One Exemption Ends 27 November 2027.

The Drug Supply Chain Security Act defines a dispenser to include any person authorized by law to dispense or administer prescription drugs, which covers a licensed practice that buys and administers them. FDA has exempted small dispensers from certain section 582 requirements until 27 November 2027.

Source: 21 U.S.C. 360eee(3); FDA, Exemptions under the DSCSA

Whether a practice counts as small is fixed as of 27 November 2026: the company that owns it must have 25 or fewer full-time employees licensed as pharmacists or qualified as pharmacy technicians. FDA asks for nothing to be submitted to use the exemption, and it urges small dispensers to keep working toward the enhanced requirements.

Source: FDA, Exemptions under the DSCSA

So why does a 503A compounded vial arrive without a product identifier, and which record should a practice keep for each kind of product it receives?

Source: 21 U.S.C. 360eee(13), (14); 21 CFR 1271.290

The rest of the issue is free for subscribers

Image: Noclipcredit

Your Free Subscription Comes With Three Things

One signup, no cost: a working checklist for the next certificate you read, the weekly digest, and a seat at the monthly briefing.

The Supplier Vetting Checklist

The first 5 of 12 questions to ask about any supplier and its certificate of analysis, as a PDF the moment you confirm your email. NPI-verified practices unlock all 12 in the free members library.

ExaBlog Weekly

Research reviews, FDA and state regulatory updates and sourcing guides every Monday, with every claim cited to its source.

Monthly live Regulatory Briefing

A live session on Google Meet on the second Tuesday evening of every month (Eastern Time) on what changed in federal and state rules. Invitations arrive by email with each date.

Benn Veyra

Every Issue Draws on Chemists, Physicians and Laboratory Scientists

ExaBlog Weekly is written by Benn Veyra, M.Sc. in organic chemistry, founder of ExaVeyra Sciences. Each issue distills what dermatologists, clinical researchers and laboratory scientists have published in peer-reviewed journals.

Authored by an organic chemist

Benn Veyra, M.Sc. in organic chemistry, writes every issue. Each summary links the paper or agency document behind it, so a reader can check the source in one click.

Insights from dermatologists

Research reviews summarize peer-reviewed studies by dermatologists and plastic surgeons, stating the study design, the sample size and what the authors concluded.

Clinical researchers

Trials, case series and consensus statements from physicians working with cell-based and biologic products, summarized together with the limitations their authors report.

Laboratory scientists

Cell biologists, pharmacologists and analytical chemists whose methods papers shape the sourcing guides, from analytical methods to certificate of analysis testing.

The physicians and scientists behind each issue are the authors of the studies it cites. ExaBlog Weekly summarizes their published work and links every source.

Each Issue Covers Three Kinds of Writing

The digest is built from what ExaBlog publishes that week, grouped so a busy reader can go straight to the part that matters to them.

Researcher in a white lab coat and gloves using a pipette at a laboratory bench beside a microscope and sample racks

Research reviews

Newly published peer-reviewed studies relevant to licensed practices. Each summary states the study design, the sample size and what the authors concluded, with the citation beside it.

Image: Rhoda Baercredit
Modern glass and brick office building entrance at the FDA White Oak campus in Silver Spring, Maryland

FDA and state regulatory updates

Guidance documents, enforcement policies, comment deadlines and state law changes, read from the primary source. Each update links the Federal Register notice, the agency page or the statute it describes.

Image: U.S. Food and Drug Administrationcredit
Gloved hands in a laboratory with vapor rolling off a block of research samples packed in dry ice on a bench

Sourcing guides

How to read a certificate of analysis, what a compliant supply chain documents, and which questions to put to any supplier. Written from the supplier side and useful with whichever vendor a practice uses.

Image: Karolina Fokcredit

Recent Issues Covered These Topics

A sample of what recent issues covered. Subscribers receive each issue in full by email every Monday.

Regulatory

DSCSA and the small-dispenser exemption

What the November 27, 2027 date means for practices that dispense, and which records a compounded vial carries instead.

Regulatory

FDA's final potency assurance guidance

How potency is measured, documented and tied to lot release, read from the November 2026 final guidance.

Sourcing guide

Reading a certificate of analysis

Which results, acceptance limits and test methods a certificate should show, and what a bare "Pass" leaves out.

Regulatory

503A and 503B compounding, compared

How the two federal categories differ in oversight, testing and the way a practice can obtain their preparations.

Subscribe Free and Read the Next Issue on Monday

One email a week, and you can unsubscribe at any time.

Educational content for licensed practitioners. Not medical or regulatory advice.

Image credits

  1. Header illustrationNoclip (English Wikipedia), Wikimedia Commons, Public domain (released by author). ↩
  2. Research reviewsRhoda Baer, National Cancer Institute, Wikimedia Commons (NCI Visuals Online), Public domain. ↩
  3. FDA and state regulatory updatesU.S. Food and Drug Administration, Wikimedia Commons, Public domain (FDA, US federal government work). ↩
  4. Sourcing guidesKarolina Fok, Wikimedia Commons, CC BY 4.0. ↩